SK3 Group's Wholesale Managed Collective Portfolio Announces New Distributor in San Diego County Expanding Company Product Reach
SK3 Group's (OTC Pink: SKTO) (PINKSHEETS: SKTO ) Medical Greens subsidiary is pleased to announce that it now has an additional new distributor in San Diego County, California for its wholesale managed collective portfolio. This step increases the reach of its wholesale managed collective portfolio into additional medical cannabis dispensaries and delivery services for its various product lines including: Dharmanol , Canna- Loz Organic Oil, T-Hydro-Can, Yak Capsules, Yeti Honeybud Oilers, Organakoil , Red Diamond Oil, Greenie Whole Plant Cookies, Haute Chocolate Instant Drink Mix, and Mocha- juana Instant Drink Mix, and opens the way for further expansion of the Pharmajanes.com delivery service.
The total population of San Diego County is over 3.1 million people, making it the second most populous county in California after Los Angeles County. The third ranked county is Orange County, where another new distributor was recently announced.
"This is an important addition to our distribution network for our various products," said Artemus Mayor, President of SK3 Group. "We continue to widen our distribution network into key markets to facilitate getting medicine to more patients who need it and building our brand across California."
About SKTO
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.
FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT:
I nvestor Relations
SK3 G roup, Inc. d.b.a Medical Greens
SOURCE: SK3 Group, Inc.
